TAmiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

We are specialized in biomarker development using cell-free RNAs such as microRNAs. MicroRNAs are evolutionary conserved regulators of gene expression and cellular function. We develop actionable diagnostic solutions that are based on combinations of microRNA biomarkers (“signatures”) and AI algorithms.

TAmiRNA is actively involved in R&D projects in liver disease (LD), senescence, cardio-vascular disease (CVD), osteoporosis (OP), and other bone and joint diseases, which are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.